Combination of PPI With A Prokinetic Drug in Gastroesophageal Reflux Disease
Combination of PPI With A Prokinetic Drug in Gastroesophageal Reflux Disease
Combination of PPI With A Prokinetic Drug in Gastroesophageal Reflux Disease
Febyan 11-2015-392
Faculty of Medicine, Christian Krida Cacana University
2
INTRODUCTION
Indonesia, is relatively lower compared to Western countries. In
Dyspepsia
United syndrome
States, nearlyand7% gastroesophageal
, and 20-40% (GERD).reflux disease (GERD)
are prevalent
Prevalence of in the community
esophagitis throughout
in the the world.
West (10-20%)
Gastroesophageal reflux disease (GERD)
Asia (only is defined as a
3-5%)
pathological condition when the amount
Japan of gastric
and Taiwan contents reflux
(13-15%).
into the esophagus exceeds the normal limit, with a variety of
There is no gender predilection on GERD
symptoms caused.
GERD can also occur in all age groups, but increases in ages over 40 years.
INTRODUCTION
INTRODUCTION
- there is a scoring system that has been developed for the screening
and evaluation of GERD therapy.
- the Frequency Scale for the Symptoms of GERD (FSSG) has been
developed in Japan to evaluate GERD symptoms.
INTRODUCTION
The National Consensus 2004 for Gastro-esophageal Reflux Disease
However,
(GERD) treatmentin in
some cases,had
Indonesia4 PPI monotherapy
mentioned that cannot
proton pump
completely resolve
inhibitor (PPIs) is
symptoms
the most in all
effective cases to
agent of GERD, and ,
treat GERD
combination therapy with prokinetic will further improve
compared to antacids, prokinetics, and H2 receptor
symptoms for some GERD patients
blockers.
METHODS
refused to participate in the study or
could not speak Indonesian
(Variable of Dependent Y)
GERD
10
METHODS
RESULTS
12
Discussion
this study found that female patients with GERD are dominant
compared to male. Mantynen (2002) examined 3378 patients with
GERD, and got the ratio of male: female was 1: 1.3. 11 In Japan,
Miyamoto studied 163 patients with GERD, 99 (60.7%) were women.
Discussion
The mean FSSG score pretreatment in this study was quite high, that
was 25.3 8.2.
According to the study of Miyamoto et al, this high score became
a factor associated with failure of PPI mono therapy. In his
study, Miyamoto et al found that a group that failed with PPI
monotherapy had a mean FSSG score of 17.4, and then that group
was given a combination therapy of PPI with prokinetic.
Discussion
Combination PPIs with prokinetics will improve the effect of PPIs.
PPIs are unstable at a low pH, dysmotility will slow down gastric
emptying, resulting in retention of PPIs.
Retention of PPIs inside the stomach for a long time may result in an
impaired acid suppressive effect, so rapid transit of the PPIs to the
upper intestine will be of benefit.
18
Discussion
The result of this study do supports this theory. This study showed
there was an improvement in FSSG score after treatment in group A
(which was given omeprazole and domperidone) as well as in
group B (omeprazole monotherapy).
Conclusion
Combination of omeprazole with domperidone in GERD patients with
high FSSG score is superior compared to omeprazole monotherapy.
The result of this study suggests the use of combination therapy of PPI
and prokinetic in GERD patients, especially with high FSSG score.
Further studies are needed to assess more about the efficacy and side
effects of drugs, with a better research design, larger sample size and
longer duration of treatment.